New York, NY, March 24, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Pharmacovigilance Market By Service Provider (In-house, and Contract Outsourcing), By Product Life Cycle (Pre-clinical, Phase I, Phase II, Phase III, and Phase IV), By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining), By Process Flow (Case Data Management, Signal Detection, and Risk Management System), By Therapeutic Area (Oncology, Neurology, Cardiology, Respiratory Systems, and Others), and By End-user (Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, and Others)Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026”.
“According to the research report, the global Pharmacovigilance Market was estimated at USD 5.68 Billion in 2019 and is expected to reach USD 12.38 Billion by 2026. The global Pharmacovigilance Market is expected to grow at a compound annual growth rate (CAGR) of 11.5% from 2019 to 2026”.
The science and practices engaged in the identification, interpretation, evaluation, and preference of adverse drug effects or other issues relating to drug surveillance shall be Pharmacovigilance. The unintended and unwelcome effect of a medication that arises during therapeutic use is the adverse medical reaction (ADR). The increasing number of ADRs is a big issue for Pharmacovigilance and will lead over the projected timeframe to a considerable rise in demand for clinical data management services. The NCBI notes that the number of deaths attributed to ADRs increased almost twice in 2014, leading to more increases in hospitalizations. The growing need for ongoing drug monitoring for reliable ADR monitoring would provide a number of opportunities for business development.
Request Your Free Sample Report of Pharmacovigilance Market @ https://www.fnfresearch.com/sample/pharmacovigilance-market
(The free sample of this report is readily available on request).
Our Free Sample Report Includes:
- 2020 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 190+ Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of table & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)
Key Questions Answered in this Report
1) What were the pre and post-business impacts of COVID-19 on the Pharmacovigilance Market?
2) What is the market size, share of the Pharmacovigilance Market?
3) Who are the top market players in Pharmacovigilance Market?
4) What will be the future market of the Pharmacovigilance Market?
Key Offerings:
- Market Size & Forecast by Revenue | 2020−2026
- Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
- Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography
- Competitive Landscape – Top key vendors and other prominent vendors
Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/pharmacovigilance-market
(You may enquire a report quote OR available discount offers to our sales team before purchase.)
Impact Analysis of COVID-19 Pandemic on Businesses: Know Short Term and Long Term Impact
Most of the businesses are facing a growing litany of business-critical concerns related to the coronavirus outbreak, including supply chain disruptions, a risk of a recession, and a potential drop in consumer spending. All these scenarios will play out differently across various regions and industries, making accurate and timely market research more essential than ever.
We at Facts and Factors (http://www.fnfresearch.com) understand how difficult it is for you to plan, strategize, or make business decisions, and as such, we have your back to support you in these uncertain times with our research insights. Our team of consultants, analysts, and experts has developed an analytical model tool for markets that helps us to assess the impact of the virus more effectively on the industrial markets. We are further implementing these insights into our reports for a better understanding of our clients.
Request Pre and Post COVID-19 Impact Analysis on Businesses: https://www.fnfresearch.com/sample/pharmacovigilance-market
Due to and a number of adverse drug reactions, secondary effects combined with potentially threatened users, the pharmaceutical industries have seen extraordinary changes. A number of public health safety acts preceded the introduction of pharmacovigilance in developing countries in the earlier 1970s, including the US and UK. The growing number of drugmakers and global harmonization practices will help support industry developments.
Industry Major Market Players
- Wipro Ltd
- United BioSource Corporation
- PAREXEL International Corporation
- TAKE Solutions Ltd.
- Linical Accelovance
- ITClinical
- IQVIA
- ICON PLC
- IBM Corporation
- Foresight Group International AG
- FMD K&L Inc.
- Cognizant
- Capgemini
- BioClinica
- ArisGlobal
- Accenture
To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/pharmacovigilance-market
Increasing acceptance and adoption of outsourcing services by healthcare companies is driving the market
Growing recognition and implementation by healthcare firms of outsourcing services would stimulate demand growth for pharmacovigilance in the years to come. The risk of overhead expenses for companies and usage of pharmacovigilance services is reduced. Outsourcing strategies enhance cost savings by reducing manufacturing firms' resource pressure. In future years, the optimistic change in trends in outsourcing pharmacovigilance due to rising advantages will lead to market growth.
In the near future, increased demand for customized drugs would encourage market growth. Personalized medication innovations would provide the industry with growth opportunities in order to improve and measure the costs and advantages of personalized drugs. Rising advances in targeted medicines such as the emergence of new clinical trial steps would further fuel pharmacovigilance demand in the coming years.
Request Customized Copy of Report @ https://www.fnfresearch.com/customization/pharmacovigilance-market
(We customize your report according to your research need. Ask our sales team for report customization.)
North America region is projected to be dominating in Pharmacovigilance market
The pharmacovigilance industry is largely dominated by North America and is predicted to continue for a few more years. The pharmacovigilance framework in the United States is changing from a passive to a positive position of healthcare systems due to the change of high expense of in-house pharmacovigilance practices against CROs. According to the study released in March 2020 by the Institute of Medicine, almost 98,000 Americans died last year because of prescription errors. Annual mortality estimates for patients have since gradually increased to 440,000 lives, making medicine errors the third leading cause of death in the world. Therefore, it is essential to reinforce the need to amend existing protocols for rapid coordination between health care services and the FDA.
Browse the full“Pharmacovigilance Market By Service Provider (In-house, and Contract Outsourcing), By Product Life Cycle (Pre-clinical, Phase I, Phase II, Phase III, and Phase IV), By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining), By Process Flow (Case Data Management, Signal Detection, and Risk Management System), By Therapeutic Area (Oncology, Neurology, Cardiology, Respiratory Systems, and Others), and By End-user (Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, and Others)Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026” report at https://www.fnfresearch.com/pharmacovigilance-market
The global Pharmacovigilance Market is segmented as follows:
By Service Provider:
- In-house
- Contract Outsourcing
By Product Life Cycle:
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
By Type:
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
By Process Flow:
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
By Therapeutic Area:
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
By End-user:
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
Related Reports:
Erectile Dysfunction Drugs Market: https://www.fnfresearch.com/erectile-dysfunction-drugs-market
Antimalarial Drugs Market: https://www.fnfresearch.com/antimalarial-drugs-market-by-drug-class-quinine-chloroquine-1128
Pharmacokinetics Services Market: https://www.fnfresearch.com/pharmacokinetics-services-market-by-drug-type-large-molecules-979
Diarrhea Drug Market: https://www.fnfresearch.com/diarrhea-drug-market-product-type-adult-diarrhea-drug-857
Anti-Hypertensive Drug Market: https://www.fnfresearch.com/anti-hypertensive-drug-market-by-type-diuretics-ace-694
About Facts & Factors (FnF Research):
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us Twitter: https://twitter.com/fnfresearch
Contact Us:
Facts & Factors
USA: +1-347-989-3985
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com
Blog: http://fnfnewsblog.com